Literature DB >> 18642942

Vav1 modulates protein expression during ATRA-induced maturation of APL-derived promyelocytes: a proteomic-based analysis.

Valeria Bertagnolo1, Silvia Grassilli, Alberto Bavelloni, Federica Brugnoli, Manuela Piazzi, Giovanni Candiano, Andrea Petretto, Mascia Benedusi, Silvano Capitani.   

Abstract

Overexpression of Vav1 promotes the overcoming of the differentiation blockade that characterizes acute promyelocytic leukemia cells. At variance, down-modulation of Vav1 prevents ATRA-induced maturation, and in particular, the inhibition of its tyrosine phosphorylation prevents the neutrophil differentiation-related changes of cell morphology. These findings allowed to identify Vav1 as a crucial protein in the ATRA-dependent differentiation of tumoral promyelocytes. By means of a proteomic approach, here we have investigated a possible role for Vav1 in modulating protein expression during ATRA treatment of tumoral promyelocytes. We have performed high-resolution 2-DE coupled with mass spectra analysis of HL-60 and NB4 promyelocytic cell lines induced to differentiate with ATRA when the amounts or the tyrosine phosphorylation of Vav1 were forcedly reduced. We have found that the down-regulation of Vav1 affects the expression level of a number of proteins, including cell cycle/apoptosis- and cytoskeleton-related proteins. In particular, the expression of 14-3-3epsilon, alpha-enolase, alpha-tubulin and splice isoform 2 of alpha3 proteasome subunit changed as a consequence of the down-modulation of Vav1 during the differentiation of both HL-60 and NB4 cell lines, suggesting that these proteins may constitute a common part of the ATRA-induced pathway during maturation of APL-derived promyelocytes. These results indicate an unprecedented role for Vav1 in the maturation of myeloid cells as a regulator of protein expression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18642942     DOI: 10.1021/pr7008719

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  12 in total

1.  Phosphorylation of c-Cbl and p85 PI3K driven by all-trans retinoic acid and CD38 depends on Lyn kinase activity.

Authors:  Johanna Congleton; Miaoqing Shen; Robert MacDonald; Fabio Malavasi; Andrew Yen
Journal:  Cell Signal       Date:  2014-03-29       Impact factor: 4.315

2.  Vav1 in hematologic neoplasms, a mini review.

Authors:  Matthew J Oberley; Deng-Shun Wang; David T Yang
Journal:  Am J Blood Res       Date:  2012-01-01

3.  Therapeutic effects of all trans-retinoic acid combined with transarterial chemoembolization on Walker-256 hepatoma in rats.

Authors:  Jianlin Fang; Chuansheng Zheng; Hongfang Tao; Hui Zhao; Jianzhuang Ren; Gansheng Feng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-02-14

4.  Quantitative proteomic analysis reveals the perturbation of multiple cellular pathways in jurkat-T cells induced by doxorubicin.

Authors:  Xiaoli Dong; Lei Xiong; Xinning Jiang; Yinsheng Wang
Journal:  J Proteome Res       Date:  2010-09-23       Impact factor: 4.466

5.  Quantitative proteomic analysis reveals the perturbation of multiple cellular pathways in HL-60 cells induced by arsenite treatment.

Authors:  Lei Xiong; Yinsheng Wang
Journal:  J Proteome Res       Date:  2010-02-05       Impact factor: 4.466

6.  6-Formylindolo (3,2-b)carbazole (FICZ) enhances retinoic acid (RA)-induced differentiation of HL-60 myeloblastic leukemia cells.

Authors:  Rodica P Bunaciu; Andrew Yen
Journal:  Mol Cancer       Date:  2013-05-09       Impact factor: 27.401

7.  In triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133high to CD133low phenotype and reduces the CD133-related invasiveness.

Authors:  Federica Brugnoli; Silvia Grassilli; Manuela Piazzi; Maria Palomba; Ervin Nika; Alberto Bavelloni; Silvano Capitani; Valeria Bertagnolo
Journal:  Mol Cancer       Date:  2013-12-13       Impact factor: 27.401

8.  High nuclear level of Vav1 is a positive prognostic factor in early invasive breast tumors: a role in modulating genes related to the efficiency of metastatic process.

Authors:  Silvia Grassilli; Federica Brugnoli; Rossano Lattanzio; Cosmo Rossi; Letizia Perracchio; Marcella Mottolese; Marco Marchisio; Maria Palomba; Ervin Nika; Pier Giorgio Natali; Mauro Piantelli; Silvano Capitani; Valeria Bertagnolo
Journal:  Oncotarget       Date:  2014-06-30

Review 9.  Vav1: A Dr. Jekyll and Mr. Hyde protein--good for the hematopoietic system, bad for cancer.

Authors:  Shulamit Katzav
Journal:  Oncotarget       Date:  2015-10-06

10.  Vav1 fine tunes p53 control of apoptosis versus proliferation in breast cancer.

Authors:  Shulamit Sebban; Marganit Farago; Dan Gashai; Lena Ilan; Eli Pikarsky; Ittai Ben-Porath; Shulamit Katzav
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.